Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design, synthesis and biological evaluation of novel guanidine-containing matrine derivatives as Topo I/II dual target inhibitors.

European journal of medicinal chemistry·2026
Same author

Design, Synthesis, and Evaluation of Cordycepin Derivatives as Antitumor Agents.

Chemistry & biodiversity·2025
Same author

Recent progress in topoisomerase inhibitors as anticancer agents: Research and design strategies for Topo I and II inhibitors via structural optimization.

Bioorganic chemistry·2025
Same author

Design, synthesis, and evaluation of novel matrine derivatives as topoisomerase I inhibitors for anticancer agents.

European journal of medicinal chemistry·2025
Same author

Diverse Development Approaches for Xanthine Oxidase Inhibitors: Synthetic Chemistry, Natural Product Chemistry, and Drug Repositioning.

Current medicinal chemistry·2025
Same author

Effects of Steroidal Compounds on Viruses.

Viral immunology·2025

Related Experiment Video

Updated: Jun 6, 2025

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.2K

Research Progress with Atractylone as an Antitumor Agent.

Ying Yao1,2, Guanghuan Shen1,2,3, Jianghan Luo1,2

  • 1College of Pharmacy, Harbin University of Commerce, Harbin 150076, China.

Molecules (Basel, Switzerland)
|November 27, 2024
PubMed
Summary

Atractylone, a compound from Rhizoma Atractylodis, shows significant antitumor activity by inhibiting tumor cell apoptosis and preventing cancer growth. This review explores its potential in cancer prevention and treatment.

Keywords:
anticanceratractylodes sesquiterpenesintestinal floramechanismtumor treatment

More Related Videos

Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis
07:50

Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis

Published on: December 8, 2023

442
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.4K

Related Experiment Videos

Last Updated: Jun 6, 2025

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.2K
Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis
07:50

Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis

Published on: December 8, 2023

442
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.4K

Area of Science:

  • Phytochemistry
  • Pharmacology
  • Oncology

Background:

  • Atractylone is a key sesquiterpenoid from Rhizoma Atractylodis.
  • It possesses diverse therapeutic properties including anti-inflammatory, antiviral, and antioxidant effects.
  • Recent research highlights its antitumor potential.

Purpose of the Study:

  • To review the antitumor activity of Atractylone.
  • To elucidate the mechanisms underlying its anticancer effects.
  • To provide a reference for future research and clinical applications.

Main Methods:

  • Literature review of existing studies on Atractylone's antitumor properties.
  • Analysis of research on its effects on apoptosis, tumor cell growth, invasion, and migration.
  • Examination of relevant signaling and apoptosis pathways.

Main Results:

  • Atractylone inhibits tumor cell apoptosis.
  • It effectively prevents tumor growth, invasion, and migration.
  • Its mechanisms involve modulation of various apoptosis and signaling pathways.

Conclusions:

  • Atractylone demonstrates significant promise as an anticancer agent.
  • It has potential for cancer prevention and reducing malignant tumor incidence.
  • Further research can guide its clinical application and development.